icon-folder.gif   Conference Reports for NATAP  
 
  16th International Workshop
on Clinical Pharmacology of HIV
and Hepatitis Therapy
May 26-28, 2015
Washington, DC
Back grey_arrow_rt.gif
 
 
 
Drug-Drug Interactions of Ombitasvir/Paritaprevir/r plus Dasabuvir with Dolutegravir or Abacavir plus Lamivudine
 
 
  Reported by Jules Levin
16th International Workshop on Clinical Pharmacology of HIV and Hepatitis Therapy, May 26-28, 2015, Washington, DC, USA
 
Amit Khatri1, Roger Trinh2, Weihan Zhao3, Thomas Podsadecki2, Rajeev Menon1 1Clinical Pharmacology and Pharmacometrics, AbbVie, North Chicago, United States; 2Infectious Disease, AbbVie, North Chicago, United States; 3Biometrics, AbbVie, North Chicago, United States

Pharm1.gif

Pharm2.gif

Pharm3.gif

Pharm4.gif

Pharm5.gif

Pharm6.gif

Pharm7.gif

Pharm8.gif

Pharm9.gif

Pharm10.gif

Pharm11.gif

Pharm12.gif